A deconvolution framework that uses single-cell sequencing plus a small benchmark data set for accurate analysis of cell type ratios in complex tissue samples
- PMID: 39586714
- PMCID: PMC11789644
- DOI: 10.1101/gr.278822.123
A deconvolution framework that uses single-cell sequencing plus a small benchmark data set for accurate analysis of cell type ratios in complex tissue samples
Abstract
Bulk deconvolution with single-cell/nucleus RNA-seq data is critical for understanding heterogeneity in complex biological samples, yet the technological discrepancy across sequencing platforms limits deconvolution accuracy. To address this, we utilize an experimental design to match inter-platform biological signals, hence revealing the technological discrepancy, and then develop a deconvolution framework called DeMixSC using this well-matched, that is, benchmark, data. Built upon a novel weighted nonnegative least-squares framework, DeMixSC identifies and adjusts genes with high technological discrepancy and aligns the benchmark data with large patient cohorts of matched-tissue-type for large-scale deconvolution. Our results using two benchmark data sets of healthy retinas and ovarian cancer tissues suggest much-improved deconvolution accuracy. Leveraging tissue-specific benchmark data sets, we applied DeMixSC to a large cohort of 453 age-related macular degeneration patients and a cohort of 30 ovarian cancer patients with various responses to neoadjuvant chemotherapy. Only DeMixSC successfully unveiled biologically meaningful differences across patient groups, demonstrating its broad applicability in diverse real-world clinical scenarios. Our findings reveal the impact of technological discrepancy on deconvolution performance and underscore the importance of a well-matched data set to resolve this challenge. The developed DeMixSC framework is generally applicable for accurately deconvolving large cohorts of disease tissues, including cancers, when a well-matched benchmark data set is available.
© 2025 Guo et al.; Published by Cold Spring Harbor Laboratory Press.
Figures





Update of
-
DeMixSC: a deconvolution framework that uses single-cell sequencing plus a small benchmark dataset for improved analysis of cell-type ratios in complex tissue samples.bioRxiv [Preprint]. 2023 Nov 11:2023.10.10.561733. doi: 10.1101/2023.10.10.561733. bioRxiv. 2023. Update in: Genome Res. 2025 Jan 22;35(1):147-161. doi: 10.1101/gr.278822.123. PMID: 37873318 Free PMC article. Updated. Preprint.
References
-
- Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57: 289–300. 10.1111/J.2517-6161.1995.TB02031.X - DOI
MeSH terms
Grants and funding
- S10 OD018033/OD/NIH HHS/United States
- P30 CA016672/CA/NCI NIH HHS/United States
- R01 CA268380/CA/NCI NIH HHS/United States
- S10 OD023469/OD/NIH HHS/United States
- P30 EY002520/EY/NEI NIH HHS/United States
- T32 CA096520/CA/NCI NIH HHS/United States
- S10 OD025240/OD/NIH HHS/United States
- R01 CA239342/CA/NCI NIH HHS/United States
- P30 CA125123/CA/NCI NIH HHS/United States
- R01 EY022356/EY/NEI NIH HHS/United States
- K22 CA234406/CA/NCI NIH HHS/United States
- S10 RR024574/RR/NCRR NIH HHS/United States
- R01 EY018571/EY/NEI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical